Could genome sequencing at birth spot rare diseases sooner? french study launches

NCT ID NCT06875089

First seen Nov 21, 2025 · Last updated May 01, 2026 · Updated 24 times

Summary

This study will test if it's possible and acceptable to screen newborns for rare diseases using genome sequencing. About 5,000 newborns in France will take part. The goal is to see if this method can quickly find treatable or actionable rare diseases, helping doctors start care earlier.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEWBORN SCREENING PROGRAMMES FOR RARE DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Besançon

    NOT_YET_RECRUITING

    Besançon, 25000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Dijon Bourgogne

    RECRUITING

    Dijon, 21000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Hôtel Dieu

    NOT_YET_RECRUITING

    Nantes, 44093, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU Rennes - Hôpital Sud

    NOT_YET_RECRUITING

    Rennes, 35203, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CHU d'Angers

    NOT_YET_RECRUITING

    Angers, 49933, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.